Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats

American Journal of the Medical Sciences

Volumn 344, Issue 6, 2012, Pages 473-479

  Zhao, Chun Mei ^a   Guo, Rui Xian ^a   Hu, Fen ^a   Meng, Jin Lan ^a,b   Mo, Li Qiu ^c   Chen, Pei Xi ^a   Liao, Xin Xue ^c   Cui, Yu ^a   Feng, Jian Qiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

MCP 1; Microglia; Morphine tolerance; Spinal cord

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE HEMOATTRACTANT PROTEIN 1 ANTIBODY; MORPHINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EXPOSURE; DRUG TOLERANCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MORPHOLOGY; NONHUMAN; RAT; SPINAL CORD; SPINAL CORD NERVE CELL; TAIL FLICK TEST;

EID: 84870901086     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31826a82ce     Document Type: Article

References (31)

1. Johnston IN, Milligan ED, Wieseler-Frank J, et al. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004;24: 7353-65.
2. Hutchinson MR, Coats BD, Lewis SS, et al. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun 2008;22: 1178-89.
3. Laing KJ, Secombes CJ. Chemokines. Dev Comp Immunol 2004;28: 443-60.
4. Geppert AM. Constitutive patterns of RANTES, MCP-1 and MIP-1 alpha expression at the mRNA and protein level during postnatal development of the rat brain. Folia Neuropathol 2003;41: 79-88.
5. Mahad DJ, Ransohoff RM. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol 2003;15: 23-32.
6. McManus C, Berman JW, Brett FM, et al. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 1998;86: 20-9.
7. Little AR, Sriram K, O'Callaghan JP. Corticosterone regulates expression of MCP-1 in the intact and chemically injured hippocampus. Neurosci Lett 2006;399: 162-6.
8. Abbadie C. Chemokines, chemokine receptors and pain. Trends Immunol 2005;26: 529-34.
9. White FA, Jung H, Miller RJ. Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A 2007;104: 20151-8.
10. Abbadie C, Lindia JA, Cumiskey AM, et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 2003;100: 7947-52.
11. Menetski J, Mistry S, Lu M, et al. Mice overexpressing chemokine ligand 2 (MCP-1) in astrocytes display enhanced nociceptive responses. Neurosci 2007;149: 706-14.
12. Tanaka T, Minami M, Nakagawa T, et al. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 2004;48: 463-9.
13. Zhang J, De Koninck Y. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem 2006;97: 772-83.
14. Bhangoo S, Ren D, Miller RJ, et al. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 2007;3: 38.
15. White FA, Sun J, Waters SM, et al. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 2005;102: 14092-7.
16. Van Steenwinckel J, Reaux-Le Goazigo A, Pommier B, et al. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci 2011;31: 5865-75.
17. Dansereau MA, Gosselin RD, Pohl M, et al. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 2008;106: 757-69.
18. Thacker MA, Clark AK, Bishop T, et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 2008;13: 263-72.
19. White FA, Bhangoo SK, Miller RJ. Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 2005;4: 834-44.
20. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends Neurosci 2005;28: 101-7.
21. Baron P, Bussini S, Cardin V, et al. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 2005; 32: 541-4.
22. Gao YJ, Zhang L, Samad OA, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009;29: 4096-108.
23. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259-74.
24. Mayer DJ, Mao J, Holt J, et al. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999;96: 7731-6.
25. Cui Y, Chen Y, Zhi JL, et al. Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res 2006;1069: 235-43.
26. Cui Y, Liao XX, Liu W, et al. A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immun 2008;22: 114-23.
27. Szabo I, Chen XH, Xin L, et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A 2002;99: 10276-81.
28. Wetzel MA, Steele AD, Eisenstein TK, et al. Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. J Immunol 2000;165: 6519-24.
29. Rock RB, Hu S, Sheng WS, et al. Morphine stimulates MCP-1 production by human neurons. J Neuroinflammation 2006;3: 32.
30. Watkins LR, Hutchinson MR, Ledeboer A, et al. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun 2007;21: 131-46.
31. Liu W, Wang CH, Cui Y, et al. Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. Neurosci Lett 2006;410: 174-7.